Zusammenfassung
Die Problematik der häufig stigmatisierenden Nebenwirkungen herkömmlicher Neuroleptika hat sich mit der Einführung moderner Antipsychotika in die Therapie der Schizophrenie entscheidend verbessert. Um eine optimale und sichere Behandlung mit diesen Substanzen zu gewährleisten, sind einige — insbesondere internistische — Aspekte zu berücksichtigen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literaturs
Schmauss M (2002) Are people with schizophrenia getting the best treatment? Ergebnisse einer europäischen Umfrage unter Patienten und Psychiatern. Poster anlässlich 6. Bad Homburger ZNS-Gespräche
US Food and Drug Administration Memorandum (14. Juni 2000) Study Report of Clinical Pharmacology Protocol 128-054
Basson BR et al. (2001) Factors influencing acute weight change In patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry 62: 231–238
Wirshing DA et al. (1999) Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 60: 358-363
Mukherjee S et al. (1996) Diabetes mellitus in Schizophrenic Patients. Compr Psychiatry 37(1): 68–73
Cavazzoni P et al. (2001) A Pharmacoepidemiological Study of Diabetes mellitus and Antipsychotic Treatment in the United States. New Clinical Drug Evaluation Unit (NCDEU) Meeting, Phoenix/USA
Marder SR, Meibach RC (1994) Risperidone in the treatment of schizophrenia. Am J Psychiatry 151: 825–835
Arvanitis LA, Miller BG (1997) Multiple fixed doses of „Seroquel“ (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry 42: 233–246
Crawford AM et al. (1997) The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations. Schizophr Res 26: 41–54
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rüther, E. (2003). Verträglichkeit moderner Antipsychotika. In: Hippius, H. (eds) 6. Bad Homburger ZNS-Gespräche. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05556-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-05556-4_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00139-3
Online ISBN: 978-3-662-05556-4
eBook Packages: Springer Book Archive